The report provides an extensive analysis of the connected drug delivery devices market, detailing profiles of leading manufacturers across North America, Europe, and Asia-Pacific. It covers clinical trials, partnerships, funding trends, and a value chain analysis, alongside case studies on asthma and diabetes, highlighting the evolution of drug delivery devices aimed at improving medication adherence. Additionally, it discusses regulatory guidelines and industry trends, offering insights into future growth potential in this sector.
The number of South Korean pharmaceutical and biotech companies pursuing IPOs has surged, with 12 firms going public this year, matching last year's total. This growth is largely driven by medical technology innovations, as five of the new listings are medtech companies, which can generate revenue through product sales. Investor interest has also been heightened by Medtronic's acquisition attempt of EOFlow, known for its wearable insulin pump.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.